1. Home
  2. CENT vs SYRE Comparison

CENT vs SYRE Comparison

Compare CENT & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Garden & Pet Company

CENT

Central Garden & Pet Company

HOLD

Current Price

$36.25

Market Cap

2.4B

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$43.98

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CENT
SYRE
Founded
1955
2013
Country
United States
United States
Employees
6000
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.6B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
CENT
SYRE
Price
$36.25
$43.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$50.00
$55.57
AVG Volume (30 Days)
58.2K
672.7K
Earning Date
01-01-0001
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.60
N/A
Revenue Next Year
$2.04
N/A
P/E Ratio
$15.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$28.77
$10.91
52 Week High
$41.25
$45.76

Technical Indicators

Market Signals
Indicator
CENT
SYRE
Relative Strength Index (RSI) 41.74 65.40
Support Level $34.52 $15.01
Resistance Level $36.36 $45.76
Average True Range (ATR) 0.84 2.18
MACD -0.40 -0.09
Stochastic Oscillator 2.58 80.37

Price Performance

Historical Comparison
CENT
SYRE

About CENT Central Garden & Pet Company

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: